C. Lepage
Oncologie, Vol.21, No.2, pp. 113-117, 2019, DOI:10.3166/onco-2019-0051
Abstract Little is known about the epidemiology of digestive
neuroendocrine tumours (NETs). NETs remain a rare cancer,
representing 1% of all digestive cancers. In France, incidence
rates are estimated to around 1.1/100,000 inhabitants in males
and 0.9/100,000 in females. The incidence rates got increased
over time, with probably more than 1,000 new cases per year
in France. Because of their relatively good prognosis, NETs
are the second more prevalent digestive cancer after colorectal
cancer. Most digestive NETs are well-differentiated (WDNETs); poorly differentiated neuroendocrine carcinomas
(PDNEC) account for less than 20% of the cases in most of
the series. Among bowel-NETs, the… More >
Login
Register
